Chemoinformaics analysis of desfuranoazadiradione
Molecular Weight | 384.516 | nRot | 1 |
Heavy Atom Molecular Weight | 352.26 | nRig | 23 |
Exact Molecular Weight | 384.23 | nRing | 4 |
Solubility: LogS | -4.606 | nHRing | 0 |
Solubility: LogP | 2.86 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 24 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 64.6254 |
nHD | 0 | BPOL | 36.4426 |
QED | 0.628 |
Synth | 4.774 |
Natural Product Likeliness | 3.292 |
NR-PPAR-gamma | 0.927 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.999 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -4.939 |
MDCK | 0.0000199 |
BBB | 0.629 |
PPB | 0.86297 |
VDSS | 0.804 |
FU | 0.210105 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.647 |
CYP2c19-inh | 0.154 |
CYP2c19-sub | 0.899 |
CYP2c9-inh | 0.139 |
CYP2c9-sub | 0.083 |
CYP2d6-inh | 0.048 |
CYP2d6-sub | 0.063 |
CYP3a4-inh | 0.6 |
CYP3a4-sub | 0.893 |
CL | 4.524 |
T12 | 0.205 |
hERG | 0.025 |
Ames | 0.009 |
ROA | 0.299 |
SkinSen | 0.07 |
Carcinogencity | 0.702 |
EI | 0.057 |
Respiratory | 0.973 |
NR-Aromatase | 0.632 |
Antiviral | No |
Prediction | 0.544913 |